<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref19">
 <mixed-citation publication-type="journal" id="cit19">
  <name>
   <surname>Hoffmann</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Kleine-Weber</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Schroeder</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Krüger</surname>
   <given-names>N.</given-names>
  </name>; 
  <name>
   <surname>Herrler</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Erichsen</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Schiergens</surname>
   <given-names>T. S.</given-names>
  </name>; 
  <name>
   <surname>Herrler</surname>
   <given-names>G.</given-names>
  </name>; 
  <name>
   <surname>Wu</surname>
   <given-names>N.-H.</given-names>
  </name>; 
  <name>
   <surname>Nitsche</surname>
   <given-names>A.</given-names>
  </name>; et al. 
  <article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>. 
  <source>Cell</source>
  <year>2020</year>, 
  <volume>181</volume> (
  <issue>2</issue>), 
  <fpage>271</fpage>–
  <lpage>280</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id>.
  <pub-id pub-id-type="pmid">32142651</pub-id>
 </mixed-citation>
</ref>
